Free Trial

Aadi Bioscience (AADI) SEC Filings & 10K Form

Aadi Bioscience logo
$2.79 -0.07 (-2.45%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$2.80 +0.00 (+0.18%)
As of 02/21/2025 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Aadi Bioscience SEC Filings

DateFilerForm TypeView
02/19/2025
4:08 PM
Aadi Bioscience (Filer)
Form DEFA14A
02/14/2025
1:00 PM
Aadi Bioscience (Subject)
QVT Financial LP (Filed by)
Form SCHEDULE 13G
02/14/2025
11:11 AM
Aadi Bioscience (Subject)
EcoR1 Capital, LLC (Filed by)
Form SCHEDULE 13G/A
02/04/2025
10:11 AM
Aadi Bioscience (Subject)
BML Investment Partners, L.P. (Filed by)
Form SCHEDULE 13D/A
01/31/2025
4:09 PM
Aadi Bioscience (Filer)
Form DEFM14A
01/30/2025
2:32 PM
Aadi Bioscience (Subject)
BML Investment Partners, L.P. (Filed by)
Form SCHEDULE 13D
01/29/2025
6:01 PM
Aadi Bioscience (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
01/24/2025
1:34 PM
Aadi Bioscience (Subject)
ACUTA CAPITAL PARTNERS, LLC (Filed by)
Form SCHEDULE 13D/A
01/21/2025
3:54 PM
Aadi Bioscience (Filer)
Form PREM14A
12/31/2024
10:13 AM
Aadi Bioscience (Subject)
BML Investment Partners, L.P. (Filed by)
Form SCHEDULE 13D
12/30/2024
4:04 PM
Aadi Bioscience (Filer)
Form DEFA14A
12/23/2024
4:34 PM
Aadi Bioscience (Issuer)
Zhao Baiteng (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/23/2024
4:36 PM
Aadi Bioscience (Issuer)
Zhao Baiteng (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
4:26 PM
Aadi Bioscience (Subject)
Desai Neil (Filed by)
Form SCHEDULE 13D/A
12/23/2024
2:51 PM
Aadi Bioscience (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SCHEDULE 13D/A
12/20/2024
5:05 AM
Aadi Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
5:08 AM
Aadi Bioscience (Filer)
Form DEFA14A
11/06/2024
3:08 PM
Aadi Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
7:05 AM
Aadi Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
6:01 PM
Aadi Bioscience (Subject)
Lennon David James (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
6:03 PM
Aadi Bioscience (Issuer)
Lennon David James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:35 PM
Aadi Bioscience (Subject)
Desai Neil (Filed by)
Form SC 13D/A
09/30/2024
5:06 AM
Aadi Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:13 PM
Aadi Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
4:55 PM
Aadi Bioscience (Issuer)
Desai Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
4:51 PM
Aadi Bioscience (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G
09/03/2024
9:40 AM
Aadi Bioscience (Subject)
Desai Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
3:42 PM
Aadi Bioscience (Subject)
BML Investment Partners, L.P. (Filed by)
Form SC 13G
08/22/2024
3:15 PM
Aadi Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
8:21 PM
Aadi Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
3:16 PM
Aadi Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
7:02 AM
Aadi Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
5:49 PM
Aadi Bioscience (Issuer)
Desai Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
5:37 PM
Aadi Bioscience (Issuer)
Desai Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:18 PM
Aadi Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:25 PM
Aadi Bioscience (Issuer)
Desai Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:26 AM
Aadi Bioscience (Subject)
Desai Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2024
7:07 AM
Aadi Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
3:05 PM
Aadi Bioscience (Filer)
Form 424B5
05/01/2024
7:50 PM
Aadi Bioscience (Issuer)
Desai Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
11:15 PM
Aadi Bioscience (Filer)
Form EFFECT
Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)

This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.
04/26/2024
3:50 PM
Aadi Bioscience (Issuer)
BALL BRYAN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/26/2024
3:56 PM
Aadi Bioscience (Filer)
Form ARS
04/26/2024
1:33 PM
Aadi Bioscience (Filer)
Form DEFA14A
04/26/2024
1:31 PM
Aadi Bioscience (Filer)
Form DEF 14A
04/04/2024
3:08 PM
Aadi Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
3:19 PM
Aadi Bioscience (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2024
7:08 AM
Aadi Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
6:12 PM
Aadi Bioscience (Issuer)
Giacobello Scott M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:15 PM
Aadi Bioscience (Issuer)
Lennon David James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:18 PM
Aadi Bioscience (Issuer)
ITRI LORETTTA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:22 PM
Aadi Bioscience (Issuer)
Desai Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
12:07 PM
Aadi Bioscience (Subject)
Desai Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AADI) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners